» Articles » PMID: 28117925

Blood-brain Barrier Permeability of Normal-appearing White Matter in Patients with Vestibular Schwannoma: A New Hybrid Approach for Analysis of T -W DCE-MRI

Overview
Date 2017 Jan 25
PMID 28117925
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To develop and assess a "hybrid" method that combines a first-pass analytical approach and the Patlak plot (PP) to improve assessment of low blood-brain barrier permeability from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) data.

Materials And Methods: Seven patients with vestibular schwannoma were enrolled. T -W DCE imaging was acquired on a 1.5T scanner. Normal-appearing white matter (NAWM) was divided into four regions of interest (ROIs) based on the magnitude of changes in longitudinal relaxation rate (ΔR1) after gadolinium administration. Kinetic analysis of ROI-averaged contrast agent concentration curves was performed using both the conventional PP and the hybrid method. Computer simulated uptake curves that resemble those from NAWM were analyzed with both methods. Percent deviations (PD) of the "measured" values from the "true" values were calculated to evaluate accuracy and precision of the two methods.

Results: The simulation showed that, at a noise level of 4% (a noise level similar to the in vivo data) and using a signal intensity (SI) averaging scheme, the new hybrid method achieved a PD of 0.9 ± 2.7% for v , and a PD of -5.4 ± 5.9% for K . In comparison, the PP method obtained a PD of 3.6 ± 11.3% for v , and -8.3 ± 12.8% for K . One-way analyses of variance (ANOVAs) showed significant variations from the four WM regions (P < 10 for ΔR1; P < 10 for K ; P < 10 for v ).

Conclusion: Both computer simulation and in vivo studies demonstrate improved reliability in v and K estimates with the hybrid method.

Level Of Evidence: 3 Technical Efficacy: Stage 1 J. MAGN. RESON. IMAGING 2017;46:79-93.

Citing Articles

A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis.

Li K, Lewis D, Zhu X, Coope D, Djoukhadar I, King A Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765090 PMC: 10534691. DOI: 10.3390/ph16091282.


Time-efficient measurement of subtle blood-brain barrier leakage using a T mapping MRI protocol at 7 T.

van den Kerkhof M, Voorter P, Canjels L, de Jong J, van Oostenbrugge R, Kroon A Magn Reson Med. 2020; 85(5):2761-2770.

PMID: 33349996 PMC: 7898690. DOI: 10.1002/mrm.28629.


MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.

Raja R, Rosenberg G, Caprihan A Neuropharmacology. 2017; 134(Pt B):259-271.

PMID: 29107626 PMC: 6044415. DOI: 10.1016/j.neuropharm.2017.10.034.

References
1.
Zeng Y, Liao H, Qin T, Zhang L, Wei W, Liang J . Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy. Oncotarget. 2015; 6(10):8366-76. PMC: 4480758. DOI: 10.18632/oncotarget.3187. View

2.
Wong P, Leppert I, Roberge D, Boudam K, Brown P, Muanza T . A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapy. Oncotarget. 2016; 7(32):50986-50996. PMC: 5239453. DOI: 10.18632/oncotarget.9653. View

3.
Tofts P . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997; 7(1):91-101. DOI: 10.1002/jmri.1880070113. View

4.
Volz S, Noth U, Deichmann R . Correction of systematic errors in quantitative proton density mapping. Magn Reson Med. 2011; 68(1):74-85. DOI: 10.1002/mrm.23206. View

5.
Chang L, Guan Koay C, Basser P, Pierpaoli C . Linear least-squares method for unbiased estimation of T1 from SPGR signals. Magn Reson Med. 2008; 60(2):496-501. PMC: 4196213. DOI: 10.1002/mrm.21669. View